There is a need to redefine Glucagon-Like Peptide-1 (GLP-1) therapy to adopt metabolism first path towards diabetes care, says Hummsa Biotech founder Harshad Lalwani.“Biotechnology company,
A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined
German pharmaceutical giant Bayer plans to adopt a strong tiered pricing approach worldwide to make its drugs and therapies affordable. However, Stefan Oelrich, head of
The National Company Law Tribunal (NCLT), Mumbai Bench, has approved Hindustan Unilever Limited’s (HUL) plan to demerge its ice cream business into a new entity
The Indian Council of Agricultural Research (ICAR) has strongly refuted allegations made by the Coalition for a GM-Free India that it “rigged and hyped” test
Merck, known as MSD outside of the United States and Canada, announced the presentation of findings from a systematic literature review of studies on the
The Drugs Control Administration (DCA) in Telangana has cracked down on the illegal sale of the potent cardiac stimulant, mephentermine sulphate injection, following a raid